At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Intravascular Filter Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
RexMedical- Option* Vena Cava Filter IDE Study
In Brief
A clinical study evaluating Intravascular Filter Device for Pulmonary Embolism. Completed, enrolled 100 participants across 10 sites.
Detailed Summary
This study is designed to evaluate the safety and efficacy of the RexMedical Option\* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Embolism
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartOct 2006
First PostedJun 2007
Primary CompletionDec 2008
Study CompletionJun 2009
TodayJul 2026
First PostedJun 20, 2007
Enrollment StartOct 1, 2006
Primary CompletionDec 1, 2008
Study CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 19.0 years ago
Interventions
Intravascular Filter Devicedevice
Vena cava filter which is implanted into the inferior vena cava of patients to prevent recurrent pulmonary embolism. The filter can be utilized as a permanent or retrievable device.